SG Healthcare Co., Ltd.

SG Healthcare Co., Ltd.

KKRX:398120
2,350.00
KRW
-15.00
(-0.63%)
107.77EPS
18.07P/E
23.26BMarket Cap
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
4,240.96
3,600.38
1,752.33
2,261.32
2,640.99
Basic EPS, GAAP
-75
229
-386
86
112.05
Free Cash Flow per Basic Share
-338.01
-91.35
-319.44
-633.14
71.27
Dividend per Share
- -
- -
- -
- -
- -
Book Value per Share
-145.22
1,200.01
2,103.17
2,179.47
2,153.09
Tangible Book Value per Share
-160.55
1,167.52
2,091.07
2,080.7
2,037.07
Basic Weighted Avg Shares
6
8
9
11
10
Sales/Revenue/Turnover
25,499
27,779
16,105
24,601
25,956
Operating Margin (%)
6.9
8.09
-4.18
5.96
6.21
Depreciation Expense
296
304
369
640
- -
Net Income, GAAP
-451
1,767
-3,547
936
1,101
Effective Tax Rate (%)
- -
16.04
- -
9.86
22.08
Profit Margin (%)
-1.77
6.36
-22.03
3.8
4.24
Working Capital
-6,108
6,425
15,903
11,482
11,925
LT Debt
1,732
116
3,815
197
142
Total Equity
-1,608
13,355
22,701
24,351
25,158
Return on Invested Capital (%)
- -
12.97
- -
4.38
4.29
Return on Capital (%)
- -
17.56
- -
4.08
4.4
Return on Common Equity (%)
- -
- -
-19.76
4.02
4.71

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
8,639
7,584
7,627
LT Borrowings
- -
- -
- -
LT Finance Leases
197
170
142
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
11
11
11
Market Capitalization
32,884
49,745
23,264

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
26,951
25,347
24,580
Cash, Cash Equivalents & STI
2,362
4,082
5,176
Accounts Receivable, Net
12,554
11,060
9,747
Inventories
8,083
6,403
6,364
Total Current Liabilities
15,470
12,508
12,655
Payables & Accruals
- -
- -
- -
ST Debt
8,639
7,584
7,627
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
7.27%
Free Cash Flow
- -
- -
134.62%
Net Income, GAAP
- -
- -
-126.37%
Sales/Revenue/Turnover
- -
- -
52.76%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,969
8,366
2,194
3,576
16,105
2025
3,664
4,116
5,122
11,699
24,601
2026
4,942
4,193
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-71
181
-114
-326.59
-386
2025
-38
-34
7
152.36
86
2026
2.43
-55
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Jung-Soo Kim
Full Time Employees
39
Sector
Health technology
Industry
Medical specialties
Address
Icheon-si South Korea
Business
SG HealthCare Co., Ltd. is a South Korea-based medical device manufacturer specializing in the development, production, and distribution of advanced diagnostic imaging equipment and artificial intelligence-driven medical software solutions. Founded in 2009 and headquartered in Icheon-si, Gyeonggi-do, South Korea, the company provides a comprehensive diagnostic imaging portfolio across human and veterinary healthcare sectors. The company operates through diversified medical imaging product lines, offering digital radiography systems, including the Jumong series of ceiling-suspended, floor-mounted, mobile, and digital retrofit X-ray units as well as dual-purpose radiography and fluoroscopy systems; surgical C-arm fluoroscopy systems marketed under the Garion brand for real-time intraoperative visualization; multi-slice computed tomography scanners under the Dominus brand; magnetic resonance imaging systems under the Invictus brand, incorporating helium-free superconducting magnet technology; dental cone beam computed tomography devices marketed under the Hasla brand; portable and cart-based diagnostic ultrasound systems; proprietary artificial intelligence software platforms, including IAIA and ARIA, engineered for real-time medical image processing, noise reduction, radiation dose reduction, and computer-aided diagnostics; and specialized veterinary digital imaging equipment tailored for animal hospitals and clinics. SG HealthCare delivers its imaging modalities and software solutions to general hospitals, specialized medical clinics, commercial diagnostic centers, dental practices, and veterinary institutions across more than 80 countries worldwide, including markets throughout Asia, Europe, the Middle East, Latin America, and Africa. In recent corporate developments, SG HealthCare completed its public listing on the KOSDAQ market of the Korea Exchange under ticker symbol 398120 in December 2024 via a reverse merger with Hana Financial 22 Special Purpose Acquisition Company. In tandem with its public listing, the company has expanded its business strategy from standalone device manufacturing toward integrated healthcare service platforms, establishing international diagnostic center hubs, such as the Seoul Medical Center initiative in Central Asia, and accelerating the commercial rollout of proprietary AI deep-learning denoising algorithms across its diagnostic imaging product suite.